Vadodara: A 60-year-old man suffering from end-stage renal disease has been given a new lease of life after undergoing a ...
Travere Therapeutics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved FILSPARI® (sparsentan) to reduce proteinuria in adult and pediatric patients aged 8 years and ...
India Today on MSN
What I wish my patients knew about staying healthy, doctor says
Dr Gaurangi Shah clarifies common misconceptions about lifestyle diseases, and offers three practical clues she wished ...
The National Kidney Registry (NKR) announced the launch of the Nutcracker Care Network (NCN), a national collaboration of leading transplant centers dedicated to advancing awareness, treatment, and ...
With one in four adults suffering from above-normal blood pressure levels in India, a new twice-yearly injectable, currently ...
Defective vitamin D supplements are causing severe health problems. Children have suffered acute kidney injuries and impaired ...
The U.S. cardiology associations have published new guidelines for the first time since 2018, aiming to detect heart risk ...
In line with earlier studies of the general population, the findings should encourage a thoughtful approach to calcium, ...
MISSISSAUGA, ON, April 7, 2026 /CNW/ - Amgen Canada announced today that the Governments of Ontario and Quebec have expanded public reimbursement of Repatha(R) (evolocumab injection) for eligible ...
RAPIBLYK (R) is an ultra-short-acting, selective beta-1 adrenergic receptor blocker administered intravenously in a monitored hospital setting. Its pharmacological profile allows for rapid onset and ...
Background Rapid access chest pain (RACP) clinics are designed to expedite cardiac assessment, but current pathways cause ...
NEW ORLEANS, LA—Adding the factor XIa inhibitor asundexian (Bayer) to antiplatelet therapy tops antiplatelet therapy alone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results